Citation Impact
Citing Papers
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
2018
Hepatic metabolism of retinoids and disease associations
2011
Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial
2002
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
DNA‐Coated AFM Cantilevers for the Investigation of Cell Adhesion and the Patterning of Live Cells
2008 StandoutNobel
Loading of Vesicles into Soft Amphiphilic Nanotubes using Osmosis
2015 StandoutNobel
Plasma Vitamins E and A Inversely Correlated to Mortality from Ischemic Heart Disease in Cross‐Cultural Epidemiology
1989
The changing landscape of atherosclerosis
2021 StandoutNature
Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.
1991
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
2007 Standout
Concanavalin A for in vivo glucose sensing: A biotoxicity review
2006
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
1999
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 Standout
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
The apolipoprotein(a) gene resides on human chromosome 6q26?27, in close proximity to the homologous gene for plasminogen
1988
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Biodegradable block copolymers as injectable drug-delivery systems
1997 StandoutNature
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Effects of fibrates on serum lipids and atherosclerosis
1988
Highly stretchable and tough hydrogels
2012 StandoutNature
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Environment-sensitive hydrogels for drug delivery
2001 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
2000 Standout
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
Stimulus-responsive hydrogels: Theory, modern advances, and applications
2015
Adherence to a Mediterranean Diet and Survival in a Greek Population
2003 Standout
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population
1995 Standout
Changes in Energy Expenditure Resulting from Altered Body Weight
1995 Standout
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Stimuli-responsive polymers and their applications in drug delivery
2009
Highly stretchable, transparent ionic touch panel
2016 StandoutScience
Lipoprotein(a). A unique risk factor for atherothrombotic disease.
1990
Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts.
1976 StandoutNobel
Genetic Models of Human Vascular Disease
1995 StandoutNobel
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
The Interaction between Human Plasma Lipoproteins and Connective Tissue Glycosaminoglycans
1972
Tissue Engineering
1993 StandoutScience
Formation of poly(glucosyloxyethyl methacrylate)-Concanavalin A complex and its glucose-sensitivity
1995
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
1980
Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTS
1974
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Polymeric Systems for Controlled Drug Release
1999 Standout
Hydrogels for Protein Delivery
2012
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia
1984
Preparation of poly(2‐glucosyloxyethyl methacrylate)‐concanavalin A complex hydrogel and its glucose‐sensitivity
1996
Immunoassay of human plasma apolipoprotein B
1975
THE TROMSØHEART-STUDY
1977
High density lipoprotein as a protective factor against coronary heart disease
1977 Standout
Plant sterols as cholesterol-lowering agents: Clinical trials in patients with hypercholesterolemia and studies of sterol balance
1977
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
1973
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Pulsatile drug delivery systems using hydrogels
1993
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Environment-sensitive hydrogels for drug delivery
2012
LIPID ABNORMALITIES IN MALE AND FEMALE SURVIVORS OF MYOCARDIAL INFARCTION AND THEIR FIRST-DEGREE RELATIVES
1972
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 StandoutNobel
The Mysteries Of Lipoprotein(a)
1989 Science
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.
1977
The Future of Genetic Studies of Complex Human Diseases
1996 StandoutScience
Genetic Dissection of Complex Traits
1994 StandoutScience
A comparison of the effect of diets containing beef protein and plant proteins on blood lipids of healthy young men
1984
Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans
1976 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Precipitation methods for quantification of lipoproteins
1986
FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
1973
The Pathogenesis of Atherosclerosis
1976 Standout
Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man
1984
Polymers for controlled parenteral delivery of peptides and proteins
1993
Integration of Porous Coordination Polymers and Gold Nanorods into Core–Shell Mesoscopic Composites toward Light-Induced Molecular Release
2013 StandoutNobel
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population
1981
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
1987
New Methods of Drug Delivery
1990 Science
Works of Dana E. Wilson being referenced
Novel aspects of vitamin A metabolism in the dog: distribution of lipoprotein retinyl esters in vitamin A-deprived and cholesterol-fed animals
1987
Concanavalin a Microspheres for a Self‐Regulating Insulin Delivery System
1992
Familial Dyslipidaemic Hypertension and Other Multiple Metabolic Syndromes
1992
The genetics of quantitative plasma Lp(a): Analysis of a large pedigree
1983
Self-regulated glycosylated insulin delivery
1990
Plasma lipoprotein retinoids after vitamin A feeding in normal man: Minimal appearance of retinyl esters among low-density lipoproteins
1983
Familial Type IV Hyperlipoproteinemia
1969
The Treatment of Hyperlipidemia
1971
A self-regulating insulin delivery system. II. In vivo characteristics of a synthetic glycosylated insulin
1989
Metabolic relationships among the plasma lipoproteins
1972
A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation.
1973
Dual-Precipitation Method for Lipoprotein Quantitation: Improvement by Membrane Ultrafiltration of Lipemic Samples
1974
Postchallenge plasma lipoprotein retinoids: Chylomicron remnants in endogenous hypertriglyceridemia
1985
Retinyl ester retention in chronic renal failure Further evidence for a defect in chylomicron remnant metabolism
1985